News

SGLT2 inhibitors improves cardiovascular outcomes across a broad range of heart and kidney conditions

Learn More

SMART-C launches institutional GitHub organisation

Learn More

SGLT2 inhibitors offer clear and powerful protection against kidney disease progression in people with and without diabetes

Learn More

Academic Affiliations

smart-c academic affiliations logos

Get in touch with us

Let's Talk

Copyright 2023 SMART-C. All rights reserved.

Privacy Policy

Terms and Conditions